Pneumococcal disease describes a group of illnesses caused by the bacterium Streptococcus pneumoniae, also known as pneumococcus. This bacterial pathogen, which affects both children and adults, is a major cause of death and illness worldwide. In fact, according to the World Health Organization (WHO), pneumococcal disease is the number one vaccine-preventable cause of death in children younger than 5 years of age worldwide.
In recognition of National Infant Immunization Week (April 24, 2005 through April 30, 2005), the Nassau County Department of Health urges all parents to ensure that their infants and toddlers are fully protected from the following vaccine preventable diseases: diphtheria, tetanus, pertussis (whooping cough), poliomyelitis, measles, mumps, rubella, hepatitis B, haemophilus influenza (meningitis), varicella (chickenpox), pneumococcal disease and influenza.
Since 2000, U.S. infants have been routinely immunized against pneumococcal (Streptococcus pneumoniae) infection. Now, Boston researchers have made a surprising discovery about natural immunity to pneumococcus.
Global health leaders today presented new research showing that vaccinating infants against Streptococcus pneumoniae -- a bacterium that causes deadly pneumonia, meningitis and sepsis -- could substantially reduce death and serious illness among children in the developing world. If used widely, a pneumococcal conjugate vaccine could prevent hundreds of thousands of child deaths each year.
A vaccine against pneumonia and invasive pneumococcal disease, a severe form of bacterial infection, can substantially reduce hospital admissions and improve the survival of children in developing countries, concludes a trial published in this week’s issue of The Lancet.
The problem of increasing antibiotic resistance in cases of Streptococcus pneumoniae, a major cause of pneumonia, meningitis and sepsis, was dramatically reversed following the licensing and use of a new conjugate vaccine for young children in February 2000, according to research conducted at Emory University, the Atlanta Veterans Affairs Medical Center, the Centers for Disease Control and Prevention, and the Georgia Division of Public Health.
Rheumatoid arthritis patients have an approximately two-fold increased morbidity and mortality in infections compared to a population without the disease.
Pharmacists are responding to unprecedented demand for the flu vaccine in the wake of the current shortage. The pharmacist is on the front line in addressing consumers’ questions and concerns about the availability of the vaccine and in helping Americans understand the CDC’s priorities for administration of the immunization.
Infection with Streptococcus pneumoniae bacteria can cause serious illness and death. Invasive pneumococcal disease is responsible for about 200 deaths each year among children under 5 years old.
The pneumococcal vaccination, the first of three new free child vaccines being introduced by the McGuinty government, is now available, Health and Long-Term Care Minister George Smitherman announced today.
The Commonwealth Government will provide free vaccines to protect newborn babies and older people from pneumococcal disease, as well as a catch up program for toddlers.